# liraglutide

NDC: 81607-019
Generic name: liraglutide
Labeler / Manufacturer: Orbicular Pharmaceutical Technologies Private Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20260226

FDA application: ANDA217234

## Active ingredients

- LIRAGLUTIDE: 6 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"81607-019"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=81607-019
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2bfc30a-8392-4255-a4d8-fa0b8d1659b2